M. Cimitan

903 total citations
22 papers, 661 citations indexed

About

M. Cimitan is a scholar working on Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging and Surgery. According to data from OpenAlex, M. Cimitan has authored 22 papers receiving a total of 661 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pulmonary and Respiratory Medicine, 8 papers in Radiology, Nuclear Medicine and Imaging and 5 papers in Surgery. Recurrent topics in M. Cimitan's work include Prostate Cancer Treatment and Research (8 papers), Medical Imaging Techniques and Applications (7 papers) and Prostate Cancer Diagnosis and Treatment (7 papers). M. Cimitan is often cited by papers focused on Prostate Cancer Treatment and Research (8 papers), Medical Imaging Techniques and Applications (7 papers) and Prostate Cancer Diagnosis and Treatment (7 papers). M. Cimitan collaborates with scholars based in Italy, Slovenia and Ukraine. M. Cimitan's co-authors include Eugenio Borsatti, Vincenzo Canzonieri, Sandro Morassut, Tanja Baresic, Annalisa Drigo, M. Trovò, A. Garbeglio, Roberto Bortolus, Luca Balestreri and Giovanni Franchin and has published in prestigious journals such as Journal of Clinical Oncology, Gastroenterology and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

M. Cimitan

22 papers receiving 647 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. Cimitan Italy 10 425 337 124 115 73 22 661
E Robinson Israel 9 352 0.8× 279 0.8× 226 1.8× 125 1.1× 58 0.8× 13 690
Alessandro Magli Italy 14 553 1.3× 230 0.7× 116 0.9× 104 0.9× 39 0.5× 33 752
Anna Margherita Maffione Italy 15 239 0.6× 387 1.1× 244 2.0× 193 1.7× 30 0.4× 51 712
C. Hashizume Japan 14 354 0.8× 183 0.5× 55 0.4× 73 0.6× 46 0.6× 35 587
Vanessa Di Cataldo Italy 14 296 0.7× 124 0.4× 170 1.4× 119 1.0× 48 0.7× 61 579
Henry Tsai United States 16 521 1.2× 128 0.4× 183 1.5× 287 2.5× 43 0.6× 45 867
Yelda Elcim Türkiye 12 174 0.4× 172 0.5× 73 0.6× 106 0.9× 51 0.7× 17 472
Y. Niwa Japan 15 475 1.1× 120 0.4× 201 1.6× 188 1.6× 126 1.7× 30 745
Karin Walter Germany 10 481 1.1× 252 0.7× 182 1.5× 65 0.6× 45 0.6× 17 681
Annick Van den Abbeele United States 7 337 0.8× 448 1.3× 88 0.7× 104 0.9× 13 0.2× 11 741

Countries citing papers authored by M. Cimitan

Since Specialization
Citations

This map shows the geographic impact of M. Cimitan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Cimitan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Cimitan more than expected).

Fields of papers citing papers by M. Cimitan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Cimitan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Cimitan. The network helps show where M. Cimitan may publish in the future.

Co-authorship network of co-authors of M. Cimitan

This figure shows the co-authorship network connecting the top 25 collaborators of M. Cimitan. A scholar is included among the top collaborators of M. Cimitan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Cimitan. M. Cimitan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Evangelista, Laura, et al.. (2015). The ability of 18F-choline PET/CT to identify local recurrence of prostate cancer. Abdominal Imaging. 40(8). 3230–3237. 20 indexed citations
2.
3.
Cimitan, M., Laura Evangelista, Marina Hodolič, et al.. (2014). Gleason Score at Diagnosis Predicts the Rate of Detection of 18F-Choline PET/CT Performed When Biochemical Evidence Indicates Recurrence of Prostate Cancer: Experience with 1,000 Patients. Journal of Nuclear Medicine. 56(2). 209–215. 55 indexed citations
4.
Hodolič, Marina, Virginie Huchet, Soňa Balogová, et al.. (2013). Incidental uptake of 18 F-fluorocholine (FCH) in the head or in the neck of patients with prostate cancer. Radiology and Oncology. 48(3). 228–234. 42 indexed citations
5.
Cimitan, M., Marina Hodolič, Anna Margherita Maffione, et al.. (2013). Incidental Detection of Leydig Cell Tumor Via Fluorine-18-Choline PET/CT in a Patient With Recurrent Prostate Cancer Disease. Clinical Nuclear Medicine. 38(9). 752–754. 6 indexed citations
6.
Hodolič, Marina, et al.. (2013). Metastatic Prostate Cancer Proven by 18F-FCH PET/CT Staging Scan in Patient With Normal PSA but High PSA Doubling Time. Clinical Nuclear Medicine. 38(9). 739–740. 6 indexed citations
7.
Hodolič, Marina, M. Cimitan, & Jure Fettich. (2013). Importance of Gleason score on 18F-choline PET/CT findings in patients with biochemical relapse of prostate cancer disease (PSA<1.0 ng/ml).. Journal of Clinical Oncology. 31(6_suppl). 86–86. 1 indexed citations
8.
Hodolič, Marina, et al.. (2012). Unusual F-18 Choline Uptake in Penile Metastasis From Prostate Cancer. Clinical Nuclear Medicine. 37(4). e89–e90. 3 indexed citations
9.
Gobitti, Carlo, Eugenio Borsatti, Mauro Arcicasa, et al.. (2012). Treatment of recurrent high-grade gliomas with GliaSite brachytherapy: a prospective mono-institutional Italian experience.. PubMed. 97(5). 614–9. 9 indexed citations
10.
Gobitti, Carlo, Eugenio Borsatti, Mauro Arcicasa, et al.. (2011). Treatment of recurrent high-grade gliomas with GliaSite brachytherapy: A prospective mono-institutional Italian experience. Tumori Journal. 97(5). 614–619. 7 indexed citations
11.
Antunovic, Lidija, M. Cimitan, Eugenio Borsatti, et al.. (2010). F-18-FDG PET/CT for the detection of recurrent epithelial ovarian carcinomas: correlation with histology, serum Ca125 assay and conventional radiological modalities. 37. 1 indexed citations
12.
13.
Cimitan, M., Roberto Bortolus, Sandro Morassut, et al.. (2006). [18F]fluorocholine PET/CT imaging for the detection of recurrent prostate cancer at PSA relapse: experience in 100 consecutive patients. European Journal of Nuclear Medicine and Molecular Imaging. 33(12). 1387–1398. 240 indexed citations
14.
15.
Cimitan, M., Rachele Volpe, Ezio Candiani, et al.. (1995). The use of thallium-201 in the preoperative detection of breast cancer: an adjunct to mammography and ultrasonography. European Journal of Nuclear Medicine and Molecular Imaging. 22(10). 1110–1117. 26 indexed citations
16.
Cannizzaro, Renato, I. Robieux, Roberto Sorio, et al.. (1995). Quantitative liver function by monoethylglycinexylidide (MEGX) test in liver metastases. Gastroenterology. 108(4). A454–A454. 2 indexed citations
17.
Casara, Dario, B Busnardo, & M. Cimitan. (1981). Liver metastases from differentiated thyroid carcinoma.. PubMed. 25(1-2). 53–4. 3 indexed citations
18.
Busnardo, B, et al.. (1980). Twenty-four hour variations of triiodothyronine (T3) levels in patients who had thyroid ablation for thyroid cancer, receiving T3 as suppressive treatment. Journal of Endocrinological Investigation. 3(4). 353–356. 5 indexed citations
19.
Cimitan, M., et al.. (1979). Carcinoembryonic antigen in thyroid cancer. Journal of Endocrinological Investigation. 2(3). 241–244. 5 indexed citations
20.
Busnardo, B, et al.. (1977). Relationships Between Metastases of Differentiated Thyroid Carcinoma and Serum Thyrotropin (TSH) Levels. The Journal of Clinical Endocrinology & Metabolism. 44(6). 1193–1196. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by E Robinson Breakdown of academic impact, for papers by Alessandro Magli Breakdown of academic impact, for papers by Anna Margherita Maffione Breakdown of academic impact, for papers by C. Hashizume Breakdown of academic impact, for papers by Vanessa Di Cataldo Breakdown of academic impact, for papers by Henry Tsai Breakdown of academic impact, for papers by Yelda Elcim Breakdown of academic impact, for papers by Y. Niwa Breakdown of academic impact, for papers by Karin Walter Breakdown of academic impact, for papers by Annick Van den Abbeele
Rankless by CCL
2026